Skip to content

Creative Peptides Blog

Menu
  • Home
  • Frontiers in Peptides
  • Experimental Techniques
  • News
  • Drug Discovery

Tag: Semaglutide

News

FDA approves new indication for semaglutide to reduce cardiovascular risk in diabetic patients

Novo Nordisk announced that the FDA has approved a new indication of 0.5 mg or 1 mg of Ozempic (semaglutide) for reducing the risk of major adverse cardiovascular events (MACE), …

drug discovery

The latest research report of Semaglutide

Novo Nordisk recently presented the latest data from two phase 3a clinical trials of its oral Semaglutide at the annual (ADA) meeting of the American Diabetes Association. Compared with the …

Recent Posts

  • Cell-penetrating Peptides (CPPs) Used in Drug Delivery Systems
  • Representative Peptides for In Vivo Imaging
  • Antitumor Peptides: Mechanisms, Production, and Applications
  • Most Commonly Used Peptides in Cosmetics
  • Commonly Used Condensation Agents in Peptide Solid Phase Synthesis

Categories

  • cosmetic
  • drug discovery
  • Experimental Techniques
  • FAQ
  • Frontiers in Peptides
  • Miscellanies
  • News

Do Peptide Drugs Need Acylation Blocking at Nα?

Alanine Scanning Library

Copyright © 2025 Creative Peptides Blog – OnePress theme by FameThemes